Advanced Pharmaceutical Science and Technology in Spain
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 272
Special Issue Editors
Interests: liposome; drug delivery; solubility enhancement; stimuli-sensitive; dual-targeting; cyclodextrin-in-liposome
Special Issues, Collections and Topics in MDPI journals
Interests: liposome; drug delivery; solubility enhancement; stimuli-sensitive; dual-targeting; cyclodextrin-in-liposome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Spanish scientists in the realm of pharmaceutical technology lead groundbreaking research in nanotechnology, innovative drug formulation and design techniques, biopharmaceuticals, drug formulation, personalized medicine, advanced drug delivery, gene therapies, pharmaceutical analysis and quality control methods, regenerative medicine and tissue engineering, biopharmaceutical and biotechnology advancements, and pharmacogenomics, among others. These advancements revolutionize drug delivery, formulation, and treatment strategies, promising better healthcare outcomes. Spain’s commitment to innovation is evident in its world-class research initiatives spanning academia and industry.
This Special Issue aims to spotlight these achievements, inviting contributions that showcase Spain’s leadership in advanced pharmaceutical science and technology. With a focus on novel drug delivery systems and precision medicine advancements, this Special Issue seeks to capture Spanish pharmaceutical research’s contemporary progress and landscape. Eagerly welcoming submissions, we aim to highlight Spain’s pivotal role in shaping the future of pharmaceutical innovation on a global scale.
Prof. Dr. María Luisa González Rodríguez
Prof. Dr. Antonio María Rabasco Álvarez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Spanish scientists
- pharmaceutical technology
- innovation
- drug delivery
- precision medicine
- research
- advancements
- healthcare
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
